Share

Research Finds Little Difference Among Diet Plans’ Long-Term Effectiveness

Endocrine Society’s Scientific Statement examines challenges of managing obesity Whether you pick low-carb, low fat or another diet plan, scientific research indicates each can help some people achieve modest long-term weight loss with potential improvement in health risks, according to the Scientific Statement the Endocrine Society issued today on managing obesity. The authors found the...
Share

Digging for Answers: Controlling Diabetic Microvascular Disease

Digging_796332061 Diabetic microvascular disease threatens myriad complications, even as researchers continue to make progress in understanding the underlying mechanisms. According to a new scientific statement from the Endocrine Society, glycemic control remains the key.   “Vascular complications are the major cause of morbidity and mortality in diabetic patients,” according to a new Endocrine Society scientific statement...
Share

New Data Show Dulaglutide in Combination with an SGLT-2 Inhibitor Improves Blood Sugar Control in People with Type 2 Diabetes

Dulaglutide significantly improves A1C (average blood sugar concentration over two to three months) when added to ongoing treatment with a sodium-glucose co-transporter-2 (SGLT-2) inhibitor, according to results from AWARD-10, a new Phase 3b clinical study.1 These data were published online first in The Lancet Diabetes & Endocrinology. “I’ve seen in my practice that even with...
Share

Reduced Time in Hypoglycemia Demonstrated in Recent Insulin Pump Trial

Positive results were announced this week from the study of a new insulin pump with a predictive low glucose suspend (PLGS) feature. Data showed that the system achieved the primary outcome of reducing time spent in hypoglycemia compared to sensor-augmented pump therapy alone. The company developing the device, Tandem Diabetes Care, is marketing its new...
Share

NIDDK Releases Funding Opportunity Announcements for Type 1 Diabetes Research

On February 15, the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) released 17 long-awaited Funding Opportunity Announcements (FOAs) to support a variety of research projects related to type 1 diabetes and its complications. These FOAs are supported with the recent $150 million extension of the Special Statutory Funding Program for Type 1...

Diabetes Research Articles

Get the most up to date news on diabetes research and treatment. For more information read the latest issue of Endocrine News.